Clinical Trial Update: Evaluation of ABSOLVE in Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

An update on the Phase 2 evaluation of ABSOLVE for diabetic foot ulcers by Lynch Biologics LLC; the current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• ABSOLVE

Snippet

Sponsor: Lynch Biologics LLC | Conditions: Diabetic Foot Ulcers | Phase 2 | Status: UNKNOWN